Lyme disease – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Fri, 12 Jun 2026 11:16:39 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Lyme disease – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 Study on the Effectiveness and Safety of the VLA15 Vaccine for Preventing Lyme Disease in Healthy Individuals Aged 5 and Older https://clinicaltrials.eu/trial/study-on-the-effectiveness-and-safety-of-the-vla15-vaccine-for-preventing-lyme-disease-in-healthy-individuals-aged-5-and-older/ Fri, 05 Jun 2026 10:54:17 +0000 https://clinicaltrials.eu/trial/study-on-the-effectiveness-and-safety-of-the-vla15-vaccine-for-preventing-lyme-disease-in-healthy-individuals-aged-5-and-older/ This clinical trial is focused on studying a vaccine for Lyme disease, which is an illness caused by bacteria transmitted through tick bites. The vaccine being tested is called VLA15, and it is designed to protect against six different types of the bacteria that cause Lyme disease. The vaccine is given as an injection using a pre-filled syringe. In this study, some participants will receive the VLA15 vaccine, while others will receive a placebo, which is a substance with no active ingredients.

The purpose of the study is to evaluate how well the VLA15 vaccine works in preventing Lyme disease, as well as to assess its safety and how well it is tolerated by participants. The study will also look at the immune response generated by the vaccine, which is the body’s way of defending itself against infections. Participants in the study will receive a series of injections over a period of time and will be monitored for any reactions or side effects. The study will include people aged 5 years and older who live in areas where Lyme disease is common.

Throughout the study, participants will have regular check-ups to monitor their health and any potential side effects from the vaccine. The study aims to ensure that the vaccine is safe and effective for people of different ages, including children and adults. By participating in this study, researchers hope to gather important information that could lead to a new way to prevent Lyme disease in the future.

]]>